VUMC part of new study validating curative therapy for sickle cell disease
Adetola Kassim, MBBS (Hematology and Oncology), is co-first author of the paper that reported of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.